REQUEST A DEMO
Total
USD $0.00
Search more companies

Magnum Medical, UAB (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Magnum Medical, UAB Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Magnum Medical, UAB is an enterprise located in Lithuania, with the main office in Kaunas. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 25, 2015. It currently has a total number of 29 (2025) employees. There was a net sales revenue drop of 24.79% reported in Magnum Medical, UAB’s latest financial highlights for 2024. The enterprise’s net profit margin decreased by 7.2% in 2024.

Headquarters
Karmelavos sen. Martinavos k. Martinavos g. 8
Kaunas; Kaunas County; Postal Code: LT-54475

Contact Details: Purchase the Magnum Medical, UAB report to view the information.

Basic Information
Total Employees:
Purchase the Magnum Medical, UAB report to view the information.
Registered Capital:
Purchase the Magnum Medical, UAB report to view the information.
Financial Auditors:
Purchase the Magnum Medical, UAB report to view the information.
Incorporation Date:
August 25, 2015
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Magnum Medical, UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-24.79%
Total Operating Revenue
-24.79%
Net Profit/Loss for the Period
-19.6%
Total Equity
-78.78%
Net Profit Margin
-7.2%
Return on Equity (ROE)
-21.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?